KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Sales (2017 - 2025)

Moderna (MRNA) has disclosed Return on Sales for 9 consecutive years, with 1.22% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 6.0% to 1.22% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.45% through Dec 2025, down 33.0% year-over-year, with the annual reading at 1.45% for FY2025, 35.0% down from the prior year.
  • Return on Sales for Q4 2025 was 1.22% at Moderna, down from 0.2% in the prior quarter.
  • The five-year high for Return on Sales was 0.68% in Q4 2021, with the low at 8.99% in Q1 2025.
  • Average Return on Sales over 5 years is 1.66%, with a median of 0.02% recorded in 2023.
  • The sharpest move saw Return on Sales soared 1613bps in 2021, then tumbled -708bps in 2024.
  • Over 5 years, Return on Sales stood at 0.68% in 2021, then tumbled by -57bps to 0.29% in 2022, then crashed by -73bps to 0.08% in 2023, then crashed by -1602bps to 1.16% in 2024, then fell by -5bps to 1.22% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 1.22%, 0.2%, and 5.81% for Q4 2025, Q3 2025, and Q2 2025 respectively.